Under pressure in diabetes, Novo Nordisk steps up focus on obesity drugs Ruby Khatun Khatun24 Nov 2017 9:30 AM ISTDenmark: Danish drugmaker Novo Nordisk is stepping up its efforts to treat obesity, seeking to tap into a potentially huge market as prices for its...
FDA approves Novo Nordisk fast-acting insulin Fiasp Ruby Khatun Khatun4 Oct 2017 9:57 AM ISTThe U.S. Food and Drug Administration (FDA) on Friday approved Novo Nordisk's fast-acting insulin to treat diabetes.The product, known as Fiasp, is...
Medtronic announces voluntary recall of Diabetes Infusion Sets MiniMed worldwide Ruby Khatun Khatun14 Sept 2017 10:37 AM ISTDUBLIN: Medtronic plc announced that it has started to inform patients worldwide of a voluntary recall of specific lots of infusion sets used with all...
Biocon up 5 per cent as Malaysia arm gets GMP compliance certificate Ruby Khatun Khatun10 Sept 2017 11:19 AM ISTNew Delhi: Shares of biopharmaceutical firm Biocon surged over 5 per cent after the company said its Malaysian arm Biocon Sdn Bhd has received EU GMP...
Biocon gets JDRF support for global study on diabetes molecule Ruby Khatun Khatun7 Sept 2017 10:02 AM ISTNew Delhi: Biotechnology major Biocon on Thursday said it has received financial support from the US-based JDRF for a global clinical study of its...
Biocon, Mylan Present Clinical Data on Insulin Glargine at American Diabetes Associations 77th Scientific Sessions Ruby Khatun Khatun12 Jun 2017 11:29 AM ISTMylan N.V. and Biocon Ltd. announced the presentation of new data from the insulin glargine clinical program, including the INSTRIDE studies at the...
